Protein Sciences will pitch Flublok to Connecticut home healthcare association; New biotech formed to develop cancer vaccines;

> Protein Sciences is partnering with the Connecticut Association for Healthcare at Home, which will enable it to sell its Flublok vaccine to member home-health and hospice agencies. News

> The Fight Against Cancer Innovation Trust and its partners formed Turnstone Biologics, a new biotech to develop cancer vaccines. Release

> A study published in Pediatrics showed that effectiveness of the Tdap vaccine for pertussis "decreases substantially" in adolescents after two to four years. News

> Gavi will continue to provide financial support for vaccinations and immunization programs in India, but only until 2020. Story

And Finally... The Chittoor District Medical and Health Department in India is scheduled to launch a pentavalent vaccine Thursday, but misspelled it as "pentaviolent" in a press release. An official went on to explain that the vaccine works "violently" against diseases. While a senior official later admitted the mistake, some continue to call it "violent." Story

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.